Rebus Biosystems
Life sciences company developing spatial biology platforms that enable high-throughput, high-resolution spatial genomics analysis to understand tissue biology at unprecedented scale.
Website
https://www.rebusbio.comLocation
Santa Clara, California, USA
Founded
2017
Investors
1
Categories
biotech, spatial-genomics, single-cell, genomics, research-tools
Notes
Rebus Biosystems is illuminating the spectrum of spatial discovery by developing spatial biology platforms for genomics research. The company's technology enables researchers to analyze gene expression in intact tissue samples, preserving spatial context that is lost in traditional single-cell methods.
Rebus's platform provides high-throughput, high-resolution spatial genomics analysis to accelerate research in oncology, neuroscience, and other fields.
Team
- Evan Daugharthy - Co-founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/evandaugharthy
- George Church, Ph.D. - Scientific Advisor (Harvard/MIT)
Additional Research Findings
- Founded in 2017 in Santa Clara, California
- Spatial genomics platform for tissue analysis
- Preserves spatial context in gene expression data
- High-throughput and high-resolution capabilities
- Scientific advisors include George Church
- Applications in oncology, neuroscience, and immunology
- Part of growing spatial biology market
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |